drugset / Trial / NCT00815100
Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate whether a pure heart rate-lowering agent (Ivabradine) reduces vascular inflammatory stress in patients with acute coronary syndromes
Timeline
- Start
- 2009-04
- Primary completion
- 2011-04
- Completion
- 2011-09-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ivabradine | Small molecule | 7.5 mg | — |